MiNK Therapeutics
(NASDAQ) INKT
MiNK Therapeutics Financials at a Glance
Market Cap
$63.66M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.49M
EPS (TTM)
$-2.96
P/E Ratio
-4.32
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$12.95
Volume
809
Open
$13.72
Price
$12.95
Volume
809
Open
$13.72
Previous Close
$12.95
Daily Range
$12.62 - $13.72
52-Week Range
$6.34 - $76.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$12.95
Volume
809
Open
$13.72
Previous Close
$12.95
Daily Range
$12.62 - $13.72
52-Week Range
$6.34 - $76.00
INKT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MiNK Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
Jennifer S. Buell, PhD
Website
www.minktherapeutics.comHeadquarters
New York City, NY 10010, US
INKT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-10%
Return on Assets
-88%
Earnings Yield
-23.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$63.66M
Shares Outstanding
4.97M
Volume
809
Short Interest
0.00%
Avg. Volume
300.42K
Financials (TTM)
Gross Profit
$181.75K
Operating Income
$12.49M
EBITDA
$12.31M
Operating Cash Flow
$5.93B
Capital Expenditure
$0.00
Free Cash Flow
$5.93B
Cash & ST Invst.
$13.36B
Total Debt
$5.18M
MiNK Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$38.56K
+28.4%
Gross Margin
0.00%
N/A
Market Cap
$63.66M
N/A
Market Cap/Employee
$2.77M
N/A
Employees
23
N/A
Net Income
$2.60M
-5.6%
EBITDA
$2.56M
-6.1%
Quarterly Fundamentals
Net Cash
$13.36B
+3842515.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$5.18M
N/A
Return on Assets
-87.75%
N/A
Return on Invested Capital
-10.34%
N/A
Free Cash Flow
$2.07M
-20.0%
Operating Cash Flow
$2.07M
-20.0%